Rare diseases
Investigational molecules
Locations
Ul. Polnej Rozy 6/u2, 02-798 Warsaw, Poland
Medical Concierge Centrum Medyczne in Warsaw, Poland specialises in clinical trials of conditions such as Bladder cancer, Bladder transitional cell carcinoma, Chronic kidney disease, Colitis ulcerative, and other specialisations. This site conducts important research.
The Medical Concierge Centrum Medyczne is advancing care for rare genetic skin disorders such as Recessive Dystrophic Epidermolysis Bullosa and Junctional Epidermolysis Bullosa, with trials aimed at testing innovative cell‑based therapies to improve healing and reduce disease burden.
Collaboration with leading specialists in Warsaw supports the development of treatments that could transform outcomes for affected children.
Research at the site focuses on chronic inflammatory conditions, notably Ulcerative Colitis, where investigators evaluate new biologic agents designed to induce durable remission and improve quality of life for patients.
The trial framework integrates patient‑centered endpoints to better understand therapeutic impact in real‑world settings.
At Medical Concierge Centrum Medyczne, oncology studies address advanced prostate cancer, specifically Metastatic Castration‑Resistant Prostate Cancer, by testing cutting‑edge antibody‑drug conjugates and combination immunotherapy to extend progression‑free survival.
The commercial organization behind the trials leverages a multidisciplinary team to accelerate access to promising cancer therapies.
The center’s dermatology program evaluates therapies for fragile skin conditions, building on work with epidermolysis bullosa to explore wound‑healing agents, matrix‑modulating treatments, and strategies that enhance patient comfort.
Participation in European research networks enables the site to contribute to broader advances in connective tissue disease management.
Clinical trials currently enrolling participants at this site.
A study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
PolandOrforglipron for stress urinary incontinence in women with obesity or overweight
PolandStudy of nadofaragene firadenovec alone or with gemcitabine, docetaxel or pembrolizumab in adults with non-muscle invasive bladder cancer who did not respond to BCG therapy
PolandPolandStudy on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure
PolandStudy of Nadofaragene Firadenovec for Adults with Intermediate Risk Non-Muscle Invasive Bladder Cancer
PolandStudy on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis
PolandA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
PolandRandomized Placebo‑Controlled Trial of Cenerimod for Efficacy and Safety in Adults with Systemic Lupus Erythematosus and Active Lupus Nephritis
PolandStudy on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients
PolandA Study of Cagrilintide and Semaglutide for Weight Loss in People with Type 2 Diabetes and Overweight or Obesity
PolandStudy of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
